ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer

Kyte, J. A.; Andresen, N. K.; Russnes, H. G.; Fretland, S. Ø.; Falk, R. S.; Lingjærde, O. C.; Naume, B.

doi:10.1186/s12967-020-02421-w

Journal of Translational Medicine

Article metrics
Last updated: Fri, 26 Apr 2024 22:53:12 Z

ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer

Access & Citations

3377

Article Accesses
20

Web of Science
26

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com